ClinicalTrials.Veeva

Menu

Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA) (UNMASK)

A

ApniCure

Status

Unknown

Conditions

Obstructive Sleep Apnea

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of the Study is to observe the use and utility of the Winx Sleep Therapy System in a clinical practice, for the treatment of patients with obstructive sleep apnea (OSA).

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria

  • Has a severe respiratory disorder, such as severe lung disease, pneumothorax, etc.
  • Has loose teeth or advanced periodontal disease.
  • Is under the age of 18.

Trial design

1,000 participants in 1 patient group

Winx

Trial contacts and locations

2

Loading...

Central trial contact

Lawrence Siegel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems